Phase I study of first-in-class oral triplet therapy DTRM-555 in relapsed/refractory lymphoma patients through fixed-dose combination and synthetic lethality Meeting Abstract
| Authors: | Huntington, S. F.; Schuster, S. J.; He, W.; Shen, T.; Walker, H.; Leary, L.; Boyhen, K.; Gill, J.; Chatburn, E. T.; Kennard, K.; Dwivedy, S.; Landsburg, D. J.; Porter, D. L.; Napier, E.; Hughes, M. E.; Latorre, T.; Walsh, K.; Dorsey, C.; Svoboda, J.; Addis, V.; Anderson, B. D.; Leblond, E.; Song, Y.; Zhu, J.; Deng, L.; Brander, D. M.; Ding, W.; Rosenthal, A. C.; Tun, H.; Mato, A. R. |
| Abstract Title: | Phase I study of first-in-class oral triplet therapy DTRM-555 in relapsed/refractory lymphoma patients through fixed-dose combination and synthetic lethality |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-26 |
| Language: | English |
| ACCESSION: | WOS:000454842806249 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-112944 |
| Notes: | Meeting Abstract: 5384 -- Source: Wos |
